PMID: 9448126Jun 1, 1997Paper

Surgical infections and prophylactic antibiotics: 341 consecutive cases of gallbladder surgery in the era of laparoscopic surgery

Journal of Laparoendoscopic & Advanced Surgical Techniques. Part a
N GarciaJ M Davis

Abstract

This study was undertaken to assess the use of prophylactic antibiotics (PA) in laparoscopic and open cholecystectomy with respect to the postoperative infection rate and the established criteria for PA use. A total of 341 consecutive cases for 1994 were retrospectively analyzed. PA use was deemed appropriate if the patient: was over 70 years of age, had common duct stones, jaundice, or acute cholecystitis. The infection rate of patients having an open cholecystectomy was significantly greater than the laparoscopic group (12.9% versus 1.8%, p < .001). In the laparoscopic group of patients who met the criteria for PA and received PA there were no infections as compared with those who had criteria for but did not receive PA (0% versus 22%, p < .05). Only 27% of all elective cholecystectomy patients received cefazolin while 73% of patients received extended spectrum antibiotics. In 63.2% of patients antibiotics were used with no indication for PA. In 73% of patients, an extended spectrum drug was used when a less expensive and narrower spectrum agent would have sufficed. Open cholecystectomy has a significantly higher infectious rate than closed cholecystectomy.

References

Dec 7, 1979·JAMA : the Journal of the American Medical Association·R Latorraca, R Martins
Aug 1, 1979·Archives of Surgery·F T GardnerH C Polk
Jun 27, 1977·JAMA : the Journal of the American Medical Association·M CastleS Osterhout
Nov 1, 1978·Annals of Internal Medicine·M J Finkel
Nov 1, 1978·Annals of Internal Medicine·W SchaffnerC F Federspiel
Oct 1, 1989·American Journal of Infection Control·J L Ryan
Jun 1, 1988·American Journal of Infection Control·J S GarnerJ M Hughes
May 31, 1988·American Journal of Surgery·A B Kaiser
Aug 1, 1988·Archives of Internal Medicine·J AvornM Weiner
Oct 30, 1986·The New England Journal of Medicine·A B Kaiser
Aug 1, 1973·Archives of Surgery·P J Cruse, R Foord
Oct 1, 1973·Annals of Internal Medicine·C M KuninW A Craig
Jul 13, 1970·JAMA : the Journal of the American Medical Association·W E Scheckler, J V Bennett
Mar 1, 1994·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·E P DellingerR P Wenzel
Jan 1, 1993·Archives of Surgery·C P PageD H Wittmann
Oct 1, 1996·Archives of Surgery·J M DavisP S Barie

❮ Previous
Next ❯

Citations

Jul 10, 2001·Surgical Endoscopy·A J Voitk, S G Tsao
Mar 12, 2008·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·G J Morris-StiffW G Sheridan
Feb 4, 2010·Journal of the American College of Surgeons·Levi D ProcterJoseph B Zwischenberger
Jul 11, 2013·Annals of the Royal College of Surgeons of England·F YanniG Morris-Stiff
Sep 15, 2018·Annals of Hepato-biliary-pancreatic Surgery·Sang Hoon KimHong Pil Hwang
Apr 9, 2002·Journal of Chemotherapy·S Colizza, S Rossi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde
J P Adenis, P Y Robert
Surgical Infections
Ansgar O Aasen, Jacob E Wang
© 2021 Meta ULC. All rights reserved